Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Yared

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
American Journal of Hematology|January 6, 2023
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemiaGuru Subramanian Guru Murthy, Brent R Logan, Stephanie Bo-Subait, et al.
Blood Advances|July 26, 2024
Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cellsMehmet H Kocoglu, Tim Luetkens, Jacqueline T Bork, et al.
Archives of Pathology & Laboratory Medicine|December 14, 2016
Statistical Literacy Among Academic Pathologists: A Survey Study to Gauge Knowledge of Frequently Used Statistical Tests Among Trainees and FacultyRobert L Schmidt, Deborah J Chute, Jorie M Colbert-Getz, et al.
Blood|September 27, 2021
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remissionMazyar Shadman, Marcelo Pasquini, Kwang Woo Ahn, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2023
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by <sup>18</sup>F-FDG PET/CT Imaging Following CAR-T TherapyForat Lutfi, Olga Goloubeva, Amer Kowatli, et al.
British Journal of Haematology|September 9, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphomaForat Lutfi, Noa G Holtzman, Ankit J Kansagra, et al.
Haematologica|October 16, 2025
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphomaNancy M Hardy, Jean A Yared, Tim Luetkens, et al.
Transplantation Proceedings|January 12, 2023
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center ExperienceHanan Alkhaldi, Olga Goloubeva, Aaron P Rapoport, et al.
Blood|May 10, 2022
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapyDjordje Atanackovic, Tim Luetkens, Destiny Omili, et al.
Cancer Research Communications|June 4, 2026
CAR T-Cell Kinetics, Persistence and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-Cell ALL Treated with Obecabtagene Autoleucel in the FELIX StudyClaire Roddie, William Day, Meera Raymond, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
American Journal of Hematology|January 6, 2023
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemiaGuru Subramanian Guru Murthy, Brent R Logan, Stephanie Bo-Subait, et al.
Blood Advances|July 26, 2024
Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cellsMehmet H Kocoglu, Tim Luetkens, Jacqueline T Bork, et al.
Archives of Pathology & Laboratory Medicine|December 14, 2016
Statistical Literacy Among Academic Pathologists: A Survey Study to Gauge Knowledge of Frequently Used Statistical Tests Among Trainees and FacultyRobert L Schmidt, Deborah J Chute, Jorie M Colbert-Getz, et al.
Blood|September 27, 2021
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remissionMazyar Shadman, Marcelo Pasquini, Kwang Woo Ahn, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2023
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by <sup>18</sup>F-FDG PET/CT Imaging Following CAR-T TherapyForat Lutfi, Olga Goloubeva, Amer Kowatli, et al.
British Journal of Haematology|September 9, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphomaForat Lutfi, Noa G Holtzman, Ankit J Kansagra, et al.
Haematologica|October 16, 2025
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphomaNancy M Hardy, Jean A Yared, Tim Luetkens, et al.
Transplantation Proceedings|January 12, 2023
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center ExperienceHanan Alkhaldi, Olga Goloubeva, Aaron P Rapoport, et al.
Blood|May 10, 2022
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapyDjordje Atanackovic, Tim Luetkens, Destiny Omili, et al.
Cancer Research Communications|June 4, 2026
CAR T-Cell Kinetics, Persistence and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-Cell ALL Treated with Obecabtagene Autoleucel in the FELIX StudyClaire Roddie, William Day, Meera Raymond, et al.
Pageof 13